Literature DB >> 17457092

Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours.

Mark Danta1, David Brown, Sanjay Bhagani, Oliver G Pybus, Caroline A Sabin, Mark Nelson, Martin Fisher, Anne M Johnson, Geoffrey M Dusheiko.   

Abstract

OBJECTIVE: To characterize the mode of hepatitis C virus (HCV) transmission in a recent epidemic of acute HCV in HIV-infected individuals using linked molecular and clinical epidemiological studies.
DESIGN: Individuals diagnosed with acute HCV between 1999 and 2005 at three urban HIV units in the UK were enrolled into a phylogenetic and case-control study. Phylogenetic trees were constructed from the amplified sequences of the E1/E2 region of the HCV genome and were used to compare cases with unrelated sequences. A questionnaire-based, case-control study using matched controls recruited from each HIV unit identified putative transmission factors.
RESULTS: One hundred and eleven HIV-positive men who have sex with men with acute HCV (genotype 1: 84%) were enrolled. Phylogenetic analysis of 93 E1/E2 sequences revealed seven monophyletic clusters signifying multiple independent HCV lineages co-circulating in the HIV-positive population. Permucosal rather than percutaneous transmission factors were associated with case/control status. Cases (n = 60) had more sexual partners, increased levels of high-risk sexual behaviour and were more likely to have shared drugs via a nasal or anal route in the preceding year in comparison with controls (n = 130). Sex in a group of more than two people was the strongest predictor of case/control status; odds ratios associated with participation in two or at least three types of high-risk sexual behaviour in a group were 9.16 (95% confidence interval, 3.51-23.90) and 23.50 (95% confidence interval, 9.47-58.33), respectively.
CONCLUSION: The identified co-circulating HCV lineages belong to different subtypes and genotypes, implying that rather than viral change, the epidemic is due to permucosal transmission factors that should be the focus of public health interventions.

Entities:  

Mesh:

Year:  2007        PMID: 17457092     DOI: 10.1097/QAD.0b013e3281053a0c

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  134 in total

Review 1.  Treatment of acute HCV infection.

Authors:  Jason Grebely; Gail V Matthews; Gregory J Dore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03-22       Impact factor: 46.802

2.  Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C.

Authors:  G V Matthews; S T Pham; M Hellard; J Grebely; L Zhang; A Oon; P Marks; I van Beek; W Rawlinson; J M Kaldor; A Lloyd; G J Dore; P A White
Journal:  Clin Infect Dis       Date:  2011-01-31       Impact factor: 9.079

Review 3.  Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.

Authors:  Susanna Naggie; Mark S Sulkowski
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

Review 4.  Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes.

Authors:  Yaron Rotman; T Jake Liang
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

5.  Incidence of Hepatitis C Virus Infection in the Human Immunodeficiency Virus Outpatient Study Cohort, 2000-2013.

Authors:  Taraz Samandari; Ellen Tedaldi; Carl Armon; Rachel Hart; Joan S Chmiel; John T Brooks; Kate Buchacz
Journal:  Open Forum Infect Dis       Date:  2017-06-10       Impact factor: 3.835

6.  Prevalent and incident hepatitis C virus infection among HIV-infected men who have sex with men engaged in primary care in a Boston community health center.

Authors:  Shikha Garg; Lynn E Taylor; Chris Grasso; Kenneth H Mayer
Journal:  Clin Infect Dis       Date:  2013-02-05       Impact factor: 9.079

Review 7.  HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.

Authors:  Marianne Martinello; Behzad Hajarizadeh; Jason Grebely; Gregory J Dore; Gail V Matthews
Journal:  Curr HIV/AIDS Rep       Date:  2017-06       Impact factor: 5.071

8.  Hepatitis C Virus Treatment in HIV-Coinfected Patients: No Longer Different From Monoinfection Treatment.

Authors:  Bevin Hearn; David Delbello; Joseph Lawler; Michel Ng; Alyson Harty; Douglas T Dieterich
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-11

9.  HEPATITIS C VIRUS GENOTYPES IN INJECTING DRUG USERS FROM ROMANIA.

Authors:  Camelia Sultana; Codruta Vagu; Aura Temereanca; Camelia Grancea; Josefina Slobozeanu; Simona Ruta
Journal:  Cent Eur J Med       Date:  2011-10

10.  Incident hepatitis C virus infection in men who have sex with men: a prospective cohort analysis, 1984-2011.

Authors:  Mallory D Witt; Eric C Seaberg; Annie Darilay; Stephen Young; Sheila Badri; Charles R Rinaldo; Lisa P Jacobson; Roger Detels; Chloe L Thio
Journal:  Clin Infect Dis       Date:  2013-03-26       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.